Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brieva

Showing results (351-360 of 376) with videos related to

Pageof 38
Sort By:
Frontiers in Psychiatry|July 23, 2025
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosisRocío Gómez-Ballesteros, Susana Sainz de la Maza, Mónica Borges, et al.
Revista De Neurologia|September 10, 2015
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II)O Fernandez, J C Alvarez-Cermeno, R Arroyo, et al.
Multiple Sclerosis and Related Disorders|May 5, 2022
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurologyLuis Brieva, Bonaventura Casanova Estruch, Juan Antonio García Merino, et al.
Multiple Sclerosis and Related Disorders|June 21, 2022
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosisTamara Castillo-Triviño, Rocío Gómez-Ballesteros, Mónica Borges, et al.
Patient Preference and Adherence|June 20, 2023
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple SclerosisSusana Sainz de la Maza, Jorge Maurino, Tamara Castillo-Triviño, et al.
International Journal of Molecular Sciences|June 12, 2026
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple SclerosisLucienne Costa-Frossard, Luis Brieva, Daniel Apolinar García-Estévez, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Measuring productivity loss in early relapsing-remitting multiple sclerosisSusana Sainz de la Maza, Jorge Maurino, Mónica Borges, et al.
Frontiers in Neurology|May 14, 2025
An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation studyMiguel Ángel Robles-Sánchez, Paloma Amil-Bujan, Cristina Bosch-Farré, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2021
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MSJosé I Fernández-Velasco, Jens Kuhle, Enric Monreal, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 15, 2023
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approachSusana Sainz de la Maza, Rocío Gómez-Ballesteros, Mónica Borges, et al.
Pageof 38

Showing results (351-360 of 376) with videos related to

Sort By:
Pageof 38
Frontiers in Psychiatry|July 23, 2025
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosisRocío Gómez-Ballesteros, Susana Sainz de la Maza, Mónica Borges, et al.
Revista De Neurologia|September 10, 2015
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II)O Fernandez, J C Alvarez-Cermeno, R Arroyo, et al.
Multiple Sclerosis and Related Disorders|May 5, 2022
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurologyLuis Brieva, Bonaventura Casanova Estruch, Juan Antonio García Merino, et al.
Multiple Sclerosis and Related Disorders|June 21, 2022
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosisTamara Castillo-Triviño, Rocío Gómez-Ballesteros, Mónica Borges, et al.
Patient Preference and Adherence|June 20, 2023
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple SclerosisSusana Sainz de la Maza, Jorge Maurino, Tamara Castillo-Triviño, et al.
International Journal of Molecular Sciences|June 12, 2026
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple SclerosisLucienne Costa-Frossard, Luis Brieva, Daniel Apolinar García-Estévez, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Measuring productivity loss in early relapsing-remitting multiple sclerosisSusana Sainz de la Maza, Jorge Maurino, Mónica Borges, et al.
Frontiers in Neurology|May 14, 2025
An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation studyMiguel Ángel Robles-Sánchez, Paloma Amil-Bujan, Cristina Bosch-Farré, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2021
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MSJosé I Fernández-Velasco, Jens Kuhle, Enric Monreal, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 15, 2023
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approachSusana Sainz de la Maza, Rocío Gómez-Ballesteros, Mónica Borges, et al.
Pageof 38